These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy. Bhole MV; Burton J; Chapel HM Immunol Allergy Clin North Am; 2008 Nov; 28(4):821-32, ix. PubMed ID: 18940576 [TBL] [Abstract][Full Text] [Related]
44. Intravenous immune globulin and the compromised host. Proceedings of a symposium, September 2l to 23, 1983, Dallas. Am J Med; 1984 Mar; 76(3A):1-231. PubMed ID: 6201066 [No Abstract] [Full Text] [Related]
45. [Bacterial infection and immunoglobulin]. Ohtomo N Rinsho Byori; 1985 Oct; 33(10):1138-44. PubMed ID: 4087440 [No Abstract] [Full Text] [Related]
46. Economic assessment of different modalities of immunoglobulin replacement therapy. Membe SK; Ho C; Cimon K; Morrison A; Kanani A; Roifman CM Immunol Allergy Clin North Am; 2008 Nov; 28(4):861-74, x. PubMed ID: 18940579 [TBL] [Abstract][Full Text] [Related]
47. [Duration of efficiency of pertussis immunoglobulin in the passive protection tests in mice (author's transl)]. Sabin S; Schwanig M; Schneider W Zentralbl Bakteriol A; 1981; 249(2):254-60. PubMed ID: 6267844 [TBL] [Abstract][Full Text] [Related]
48. [The dynamics of the level of antiprotein antibodies in the recipient blood serum under different conditions of the passive inoculation of rabbits with allogeneic antiprotein blood preparations]. Nazarchuk LV; Myronenko VI Fiziol Zh (1994); 1994; 40(3-4):111-5. PubMed ID: 7621948 [TBL] [Abstract][Full Text] [Related]
49. [Application of immunoglobulins in practice]. Weber-Oldecop H ZFA (Stuttgart); 1981 Jan; 57(3):169-76. PubMed ID: 7210836 [No Abstract] [Full Text] [Related]
50. [The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation]. Sedlacek HH; Seiler FR Beitr Infusionther Klin Ernahr; 1982; 9():80-94. PubMed ID: 6216882 [No Abstract] [Full Text] [Related]
51. [Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors]. Wahn V Fortschr Med; 1984 Aug; 102(31-32):795-8. PubMed ID: 6479819 [TBL] [Abstract][Full Text] [Related]
52. Genetic syndromic immunodeficiencies with antibody defects. Ming JE; Stiehm ER Immunol Allergy Clin North Am; 2008 Nov; 28(4):715-36, vii. PubMed ID: 18940571 [TBL] [Abstract][Full Text] [Related]
53. Hypogammaglobulinaemia. Yong PF; Chee R; Grimbacher B Immunol Allergy Clin North Am; 2008 Nov; 28(4):691-713, vii. PubMed ID: 18940570 [TBL] [Abstract][Full Text] [Related]
54. [New aspects of substitute treatment of primary and secondary immunologic deficiency syndromes]. Bernatowska E Pol Arch Med Wewn; 1986 Oct; 76(4):228-32. PubMed ID: 3295794 [No Abstract] [Full Text] [Related]
56. The clinical use of intravenous immunoglobulin in pediatrics. Wahn V Indian J Pediatr; 1987; 54(5):641-53. PubMed ID: 3428982 [No Abstract] [Full Text] [Related]